Drugs / autologous dendritic cell cancer vaccine
last change Apr 2008 re-read 3 minutes ago

autologous dendritic cell cancer vaccine

Vaccine

Developed for
lung cancer
Investigated by
Edward Hirschowitz · National Cancer Institute (NCI)

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00103116 Oct 2004 → Apr 2008 lung cancer Edward Hirschowitz Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as autologous dendritic cell cancer vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00103116 ↗
Modality Vaccine “Autologous dendritic cell vaccines for non-small-cell lung cancer.” PMID 15254048 ↗ Jul 2004